SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
Mossa M, Neri B, Montesano L, Salvatori S, Marafini I, Scucchi L, Lolli E, Massoud R, Petruzziello C, Bernardini S, Calabrese E, Monteleone G, Biancone L.
Mossa M, et al. Among authors: montesano l.
Eur Rev Med Pharmacol Sci. 2022 May;26(10):3787-3796. doi: 10.26355/eurrev_202205_28875.
Eur Rev Med Pharmacol Sci. 2022.
PMID: 35647861
Free article.